RENAL FUNCTION DIFFERENCE BETWEEN ANTI-HEPATITIS B IMMUNOGLOBULIN (HBIG) MONOTHERAPY AND HBIG COMBINED WITH ENTECAVIR

被引：0
|
作者：
Lee, Jae Geun [1 ]
Ju, Man Ki [1 ]
Choi, Sub Jin [1 ]
Kim, Soon Il [1 ]
Kim, Myoung Soo [1 ]
Joo, Dong Jin [1 ]
Lee, Juhan [1 ]
Song, Seung Hwan [1 ]
机构：
[1] Yonsei Univ, Seoul 120749, South Korea
来源：
TRANSPLANT INTERNATIONAL | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P624
引用
收藏
页码：707 / 707
页数：1
相关论文
共 50 条
  • [41] Early Switching to Subcutaneous Anti-Hepatitis B Virus Immunoglobulins (HBIg) after Liver Transplantation: 6-Month Results of a Single-Center Study.
    De Simone, Paolo
    Carrai, Paola
    Ducci, Juri
    Coletti, Laura
    Balzano, Emanuele
    Filipponi, Franco
    LIVER TRANSPLANTATION, 2012, 18 : S222 - S222
  • [42] Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine
    Lee, KW
    Lee, SK
    Joh, JW
    Kim, SJ
    Park, JH
    Chon, SE
    Choi, SH
    Heo, JS
    Paik, SW
    Koh, KW
    Lee, JH
    Choi, MS
    Kim, YI
    Lee, BB
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3643 - 3644
  • [43] EARLY INTRODUCTION OF SUBCUTANEOUS (SC) HEPATITIS B IMMUNOGLOBULIN (HBIg) PROVIDES EFFECTIVE PROPHYLAXIS FOR HEPATITIS B VIRUS (HBV) REINFECTION AFTER LIVER TRANSPLANTATION (TX)
    Samuel, D.
    De Simone, P.
    Salizoni, M.
    Pinna, A. D.
    Cillo, U.
    Zamboni, F.
    Mutimer, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S273 - S273
  • [44] Genetic Evidence for Genotoxic Effect of Entecavir, an Anti-Hepatitis B Virus Nucleotide Analog
    Jiang, Lei
    Wu, Xiaohua
    He, Fang
    Liu, Ying
    Hu, Xiaoqing
    Takeda, Shunichi
    Qing, Yong
    PLOS ONE, 2016, 11 (01):
  • [45] Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir
    Ying, Chunxiao
    Colonno, Richard
    De Clercq, Erik
    Neyts, Johan
    ANTIVIRAL RESEARCH, 2007, 73 (03) : 192 - 196
  • [46] Combined therapy with low dose hepatitis B immunoglobulin (HBIG) and lamivudine (LAM) in patients transplanted for HBV chronic liver disease: Long term efficacy and costs
    Giusto, M.
    Gentili, F.
    Loria, I.
    Grieco, S.
    Rossi, M.
    Novelli, G.
    Berloco, P.
    Ferretti, G.
    Corradini, S. Ginanni
    Attili, A. F.
    Merli, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S84 - S84
  • [47] EARLY INTRODUCTION OF SUBCUTANEOUS (SC) HEPATITIS B IMMUNOGLOBULIN (HBIG) PROVIDES EFFECTIVE PROPHYLAXIS FOR HEPATITIS B VIRUS (HBV) REINFECTION AFTER LIVER TRANSPLANTATION (TX)
    Roche, B.
    Zoulim, F.
    De Simone, P.
    Samuel, D.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 21 - 21
  • [48] Renal safety of entecavir and tenofovir with hepatitis B immunoglobulin in liver transplant patients
    Kim, D. G.
    Lee, J.
    Kim, S. J.
    Ihn, K.
    Lee, J. G.
    Joo, D. J.
    Kim, M. S.
    Kim, S., I
    TRANSPLANTATION, 2019, 103 (08) : 86 - 87
  • [49] Renal Safety of Entecavir and Tenofovir with Hepatitis B Immunoglobulin in Liver Transplant Patients
    Lee, J.
    Kim, E.
    Yang, S.
    Kim, D.
    Kim, S.
    Park, J.
    Choi, H.
    Kim, B.
    Joo, D.
    Kim, M.
    Kim, S.
    Lee, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1038 - 1038
  • [50] Efficacy of recombinant hepatitis B vaccine (rHBV) alone in preventing perinatal transmission of hepatitis B is similar to Combination of rHBV plus hepatitis B immunoglobulin (HBIG): A randomized controlled trial
    Pande, Chandana
    Kumar, Ashish
    Patra, Sharda
    Hazarika, Poppy
    Sarin, Shiv K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S238 - S239
12345